Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [41] Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients
    van de Garde, Ewoudt M. W.
    Bras, Leo J.
    Heijmen, Robin H.
    Knibbe, Catherijne A. J.
    van Dongen, Eric P. A.
    Wiltink, Ed H. H.
    Biesma, Douwe H.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2006, 20 (04) : 573 - 575
  • [42] Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven®):: a single centre experience
    Habermann, B
    Hochmuth, K
    Hovy, L
    Scharrer, I
    Kurth, AHA
    HAEMOPHILIA, 2004, 10 (06) : 705 - 712
  • [43] Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa
    Peter D. Winch
    Aymen N. Naguib
    Jacob R. Bradshaw
    Mark Galantowicz
    Joseph D. Tobias
    Pediatric Cardiology, 2013, 34 : 119 - 124
  • [44] Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin
    Oh, JJ
    Akers, WS
    Lewis, D
    Ramaiah, C
    Flynn, JD
    PHARMACOTHERAPY, 2006, 26 (04): : 569 - 577
  • [45] Management of thrombosis in a pediatric renal transplant patient with factor VII deficiency A dilemma concerning recombinant factor VIIa
    Yalcin, M.
    Simsek, A.
    Tabel, Y.
    Dogan, S. M.
    Piskin, T.
    ARCHIVES OF HELLENIC MEDICINE, 2020, 37 (03): : 391 - 394
  • [46] Successful outcome of a cirrhotic patient with postoperative haematuria treated with a single high dose of recombinant factor VIIa
    Lucía, JF
    Aguilar, C
    Orna, E
    Allepuz, C
    Giralt, M
    Carrasco, V
    Simón, MA
    HAEMOPHILIA, 2001, 7 (06) : 600 - 602
  • [47] Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery
    Mahmoud, Amr
    Al-Ruzzeh, Sharif
    McKeague, Helena
    Cross, Mike
    TEXAS HEART INSTITUTE JOURNAL, 2007, 34 (04): : 485 - 488
  • [48] Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven®):: a new case report and review of the literature
    Faradji, A
    Bonnomet, F
    Lecocq, J
    Grunebaum, L
    Desprez, D
    Kern, O
    Barbier, L
    Sibilia, J
    HAEMOPHILIA, 2001, 7 (03) : 321 - 326
  • [49] Successful use of recombinant factor VIIa for management of severe menorrhagia in an adolescent with an acquired inhibitor of human thrombin
    Giovannini, L
    Appert, A
    Monpoux, F
    Fischer, F
    Boutte, P
    Sirvent, N
    ACTA PAEDIATRICA, 2004, 93 (06) : 841 - 843
  • [50] Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients
    Guzzetta, Nina A.
    Russell, Isobel A.
    Williams, Glyn D.
    ANESTHESIA AND ANALGESIA, 2012, 115 (02) : 364 - 378
12345